The muscarinic receptor was studied in vivo in the human heart by a noninvasive method, positron emission tomography (PET). The study showed that the binding sites of "C-labeled methiodide quinuclidinyl benzilate (["C]-MQNB), a muscarinic antagonist, were mainly distributed in the ventricular septum (98 pmol/cm3 of heart) and in the left ventricular wall (89 pmol/cm3), while the atria were not visu- A population of specific, saturable, high-affinity muscarinic receptors in the mammalian heart was identified in vitro by using the potent muscarinic antagonist [3Hlquinuclidinyl benzilate ([3H]QNB) (1). However, the disadvantage of in vitro binding studies is that they cannot distinguish between ligand-binding sites and effector-coupled receptors; in particular, the correlation between the affinity for receptor subtypes and the biological effect of agonists is difficult to demonstrate. Furthermore, the conditions of in vitro binding studies are quite different from those governing the receptor during physiological transmission (2). The properties of muscarinic receptors studied in homogenates or after solubilization may be altered or may correspond to selective fractions of the total population (3). The accessibility of receptor sites to acetylcholine in the intact organ and in homogenates is also different. It appears that the range of acetylcholine concentrations used for in vitro binding studies of the nicotinic receptor (approximately micromolar) is much smaller than that of physiologically active concentrations in the synaptic cleft (approximately millimolar) (2). Since binding studies are performed at equilibrium, the ligand is incubated with the receptor preparation for a much longer time (minutes or hours) than that corresponding to the channel lifetime (4). Thus, the correlation between the active conformation of the receptor leading to the response (opening of ions channels) and the conformational transitions identified in vitro is difficult to establish (5).
[3H]MQNB to heart homogenates in vitro. The MQNB concentrations in the ventricular septum of different individuals were found to be highest when the heart rate at the time of injection was slow. This result suggests that the antagonist binding site is related to a low-affinity conformational state of the receptor under predominant vagal stimulation. Thus, positron emission tomography might be the ideal method to study the physiologically active form of the muscarinic acetylcholine receptor in man.
A population of specific, saturable, high-affinity muscarinic receptors in the mammalian heart was identified in vitro by using the potent muscarinic antagonist [3Hlquinuclidinyl benzilate ([3H] QNB) (1) . However, the disadvantage of in vitro binding studies is that they cannot distinguish between ligand-binding sites and effector-coupled receptors; in particular, the correlation between the affinity for receptor subtypes and the biological effect of agonists is difficult to demonstrate. Furthermore, the conditions of in vitro binding studies are quite different from those governing the receptor during physiological transmission (2) . The properties of muscarinic receptors studied in homogenates or after solubilization may be altered or may correspond to selective fractions of the total population (3) . The accessibility of receptor sites to acetylcholine in the intact organ and in homogenates is also different. It appears that the range of acetylcholine concentrations used for in vitro binding studies of the nicotinic receptor (approximately micromolar) is much smaller than that of physiologically active concentrations in the synaptic cleft (approximately millimolar) (2) . Since binding studies are performed at equilibrium, the ligand is incubated with the receptor preparation for a much longer time (minutes or hours) than that corresponding to the channel lifetime (4) . Thus, the correlation between the active conformation of the receptor leading to the response (opening of ions channels) and the conformational transitions identified in vitro is difficult to establish (5) .
In this communication we report quantitative data obtained on the dynamics of the myocardial acetylcholine receptor in man by a safe, noninvasive technique. Positron emission tomography (PET) is a visualization technique that gives an accurate and quantitative representation of the spatial distribution of a positron-emitting radionuclide in any desired transverse section of the body. Carbon-li, a shortlived positron emitter (20.4 min) can be incorporated into ligands for receptors. Owing to its short half-life, relatively large amounts of "C-labeled ligand can be intravenously injected at a high specific activity (10-100 times higher than that of a 3H-labeled ligand) with a low radiation dose to the patient. The PET approach may be compared to quantitative autoradiography with the added advantage of allowing in vivo studies in man under normal and pathological conditions.
Methiodide quinuclidinyl benzilate (MQNB) was chosen instead of QNB for in vivo PET studies of the properties of muscarinic acetylcholine receptors in the human heart because MQNB is a hydrophilic nontoxic molecule that cannot cross the blood-brain barrier and is not extracted by the lungs. Large accumulation in the heart, low nonspecific binding, and high affinity and specificity for the muscarinic receptor in rat, guinea pig, and rabbit suggest that MQNB could be an ideal radioligand for in vivo studies (6) . Using ["C]MQNB, Maziere et al. showed that the in vivo ["C]MQNB uptake in the baboon heart corresponds to specific binding to acetylcholine muscarinic receptors (7) .
In the present communication, we show that by using PET it is possible to study the localization of the muscarinic cholinergic receptor in the human heart under physiological conditions and to study the relationship between the conformational state of the receptor and the physiological response.
MATERIALS AND METHODS
Thirty-four studies were performed on 33 subjects with their informed consent. Twenty-two subjects showed no detectable sign of heart disease; the other cases included five old myocardial infarctions and six mitral or aortic valve diseases.
[ min after injection. The first 10 images were obtained in 1 min each; the acquisition time then was increased for the others so that at least 300,000 cpm were accumulated for each section. Quantitative images were corrected for 511-keV -ray attenuation and radioactive decay. Regions of interest were selected over the ventricles and the septum to measure the regional tracer concentration. The loss in cpm recovery related to the small size of the ventricular septum was corrected by using echocardiography (8) . From a calibration factor measured experimentally with a standard solution of a positron emitter, the results were expressed as the percentage of injected dose per ml of tissue, or, after multiplication, by the injected amount of MQNB in pmol/ml of tissue. One of the patients was studied with a new photon time-of-flight-assisted PET system (LETI, Commissariat a l'Energie Atomique, Grenoble, France) providing five slices simultaneously with transverse and axial spatial resolutions of 12 and 13 mm, respectively.
Blood radioactivity also was measured in venous samples at various times after MQNB at a high specific activity in a brachial vein, the ["C]MQNB blood concentration fell very rapidly to a negligible value a few minutes after intravenous injection ( Fig. 2 Upper). In contrast, the ['1C]MQNB concentration increased rapidly in the myocardium to reach a maximum in 1-5 min and then remained constant for 70 min; under these conditions the [11C]MQNB concentration was >100 times higher in heart than in blood (Fig. 2 Upper) .
In other patients the radioligand specific activity in the injectate was decreased by addition of various amounts of unlabeled MQNB (between 21 and 508 nmol/m2 of body surface area; Fig. 2 Lower). The activity-vs.-time curves in the patients injected with a dose larger than 100 nmol/m2 showed a maximum during the first minute, followed by a decrease. The larger the amount of MQNB injected in a patient, the faster the myocardial radioactivity decreased ( (Fig. 3) . Above 300 nmol-m2, the concentration became constant at 98 pmol per cm3 of septum. Relationship Between Receptor Occupancy and Heart Rate. Fig. 4 demonstrates a relationship between the percentage of MQNB found in 1 cm3 of septum after rapid intravenous injection in 12 subjects injected with comparable amounts of MQNB (between 1 and 2 nmol/kg of body weight) and the heart rate value recorded at the time of injection. Fig. 4 shows that, for a given subject, the MQNB concentration in (9) (10) (11) (12) . This discrepancy could be due to the difference in liposolubility between QNB and its N-methyl quaternary salt, MQNB (13) , since it has been suggested that hydrophobic interactions within the receptor or between the receptor and the membrane lipids are necessary for the conformational change to occur (10, 14) .
The regional distribution of receptor densities for in vivo
[1"C]MQNB binding in the human heart was found to differ somewhat from that reported by Fields et al. in rabbit, rat, and guinea pig heart homogenates with [3H]QNB (1) . In our in vivo human studies, the highest concentrations were obtained in the septum (98 pmol/cm3 of heart) and in the left ventricle (89 pmol/cm3), whereas they were found in the left and right atria with [3H]QNB in rat heart homogenates (1).
However, although rat septal and ventricular tissue contained a lower concentration of receptors per g of protein, because of their weight, these regions contained a higher percentage of acetylcholine receptors than in the atria (1).
In PET studies one must take into account the partial volume effects that lead to a loss in cpm recovery when the object size is smaller than the spatial resolution of the camera. However, even in the patient examined with the time-offlight-assisted PET system, the atria were not visualized; thus, it is likely that the regional myocardial distribution of muscarinic receptors is different in man and in rat. Indeed, a species-dependent regional distribution of cholinergic receptors has been observed in different animals: the receptor site density was highest in the right and left atria in rat and rabbit heart, whereas it was diffuse in guinea pig and dog, where 75% of the total cardiac receptors were found in the ventricles (15) . Although the existence of an abundant parasympathetic innervation of the atria is well known, that of the ventricles has been a subject of considerable controversy. Both histological and physiological data were generally considered to indicate an absence of ventricular parasympathetic innervation (16) , but in the past decade numerous data, both chemical and physiological, have proved the existence of a direct parasympathetic innervation of the mammalian ventricle (see ref. 17 for review). The ventricular muscarinic receptors are localized to sarcolemna in dog (18) ; their precise role in the modulation of biochemical and electrophysiological events at the cellular level remains a subject of considerable interest.
We showed in a recent paper that the quantitative results obtained in man when ["C]MQNB was intravenously injected were different from those obtained in vitro when [3H]QNB was incubated with heart tissue homogenates (19) .
When trace amounts of [11C]MQNB were intravenously injected, the blood activity became negligible in a few minutes because the tracer was extracted from blood not only by the heart but also by the liver where the binding is not specific (7) . Although this experiment can be compared with those performed in vitro at infinite dilution, [11C]MQNB blood concentration being 1/100th of heart concentration after 4 or 5 min, the septum radioactivity remained constant with time.
However, the rapid intravenous injection of a larger amount of unlabeled atropine resulted in a rapid decrease in cardiac radioactivity as is found in in vitro saturation experiments, the acetylcholine receptors being blocked by the unlabeled (19) .
A simple mathematical model was developed. The main result was that the higher the concentration of receptorbound ligand or the fractional receptor occupancy, the larger the ligand fraction that escapes from the boundary layer (19) . In the present study, the rate constant for the dissociation of the MQNB complex was calculated to be 0.15 min' according to this model. The same value was obtained whether atropine was injected at minute 20 or 105 after ["1C]MQNB injection, which means that the affinity of the binding sites was independent of the duration of MQNB "incubation" with the receptor and thus that, in contrast to QNB, there was no evidence of isomerization of the MQNB-receptor complex in vivo nor in vitro. The kL1 value for the dissociation of MQNB complex measured in vitro on rat heart homogenates (0.81 min') was of the same order of magnitude.
These results suggest that the main difference between MQNB binding to acetylcholine receptor in vivo and in vitro is the presence of a boundary layer in intact tissue that contains the ligand at a finite concentration in the vicinity of the receptor sites, although its concentration in interstitial tissue and blood is close to zero.
The plots of the individual MQNB septum concentrations extrapolated at t = 0 vs. the amount of MQNB (Fig. 3) seem to be similar to those of bound ligand vs. total ligand concentration obtained in vitro (20) . In both cases the plateau corresponds to the total receptor concentration. However, the linear ascending part of the curve does not represent the inverse of the total receptor concentration (1/IRTI) as in in vitro equilibrium saturation experiments when IRTI is much larger than the equilibrium dissociation constant Kd (20) .
Since [11C]MQNB was intravenously injected as a bolus and very rapidly extracted from blood to reach a stable level in myocardium, its fractional uptake must have been equal to the myocardial blood flow fraction of the cardiac output (21) . Thus, the slope of the regression line in Fig. 3 represents the ratio of the coronary blood flow per cm3 of myocardium to the cardiac index (expressed as ml min-1/m2 body surface area). The mean value calculated from 30 points corresponding to 29 different subjects was 0.417 x 10-3 m2 per cm3 of septum. By using a cardiac index value of 3500 ml-min' per M2, the mean coronary blood flow comes out to be 1.46 mlmin-' per cm3 of myocardium, which is at the upper limit of normal values (22) .
Since PET allows an in vivo analysis of muscarinic receptors in the human heart under sympathetic and parasympathetic physiological control, it is worth considering that this method might represent the ideal approach to research on the physiologically active form of the acetylcholine receptor. This hypothesis is supported by the finding of a relationship between heart rate at injection time and the percentage of the amount of MQNB intravenously injected that is found in 1 cm3 of septum. The interesting result was that the lower the heart rate in an individual, the higher the receptor occupancy by the antagonist. It has been suggested from in vitro data that the low-affinity form of the cardiac muscarinic receptor is the active form (23) (24) (25) (26) because it mediates the inhibition of adenylate cyclase (24) and the negative chronotropic response in embryonic chick atria (27) . Complex sympatheticparasympathetic interactions occur at the heart level (the force and frequency of contraction are increased by noradrenaline and decreased by acetylcholine), and at the molecular level these transmitters act upon various effector sys- (1985) increase in either the number or the affinity of antagonist binding sites. In the physiologically active state, the agonist is released from the receptor in a low-affinity form, and more sites are available for ["C]MQNB binding (28) . According to this hypothesis, vagal stimulation would elicit a selective increase in the ['1C]MQNB binding capacity of the receptor without changing the affinity of the antagonist for the receptor. The presence of two interconvertible forms of the muscarinic cholinergic receptor respectively favored by agonists and antagonists and displaying high-agonist/low-antagonist and low-agonist/high-antagonist affinities, respectively, has been demonstrated (29) . According to this hypothesis, vagal stimulation would be characterized by a conversion to the low-agonist/high-antagonist affinity form of the muscarinic receptor.
